Flutemetamol F-18: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Flutemetamol F-18. Educational only — not medical advice.
Labeled uses
VIZAMYL is indicated for positron emission tomography (PET) of the brain to estimate amyloid beta neuritic plaque density in adults with cognitive impairment for: Evaluation of Alzheimer's disease (AD) and other causes of cognitive decline Selection of patients who are indicated for amyloid beta-directed therapy as described in the prescribing information of the therapeutic products
Source: FDA labeling via NIH DailyMed (set b3558f16…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.